Search

Your search keyword '"Tio, R A"' showing total 138 results

Search Constraints

Start Over You searched for: Author "Tio, R A" Remove constraint Author: "Tio, R A" Search Limiters Full Text Remove constraint Search Limiters: Full Text
138 results on '"Tio, R A"'

Search Results

1. Electrocardiogram-based mortality prediction in patients with COVID-19 using machine learning

5. Clinician-reported EHRA and NYHA scores only moderately reflect patient-reported quality of life in atrial fibrillation and heart failure

6. Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study

7. Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries

8. GANGGUAN EMOSI PADA TOKOH UTAMA CERPEN PULANG KARYA BEJO (Suatu Kajian Psikologi Sastra)

21. Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease

22. Poster Session 1: Sunday 3 May 2015, 08:30-18:00 * Room: Poster Area

23. Reduction of endothelial dysfunction following VEGF gene therapy

24. A prospective validation of the HEART score for chest pain patients at the emergency department.

25. A prospective validation of the HEART score for chest pain patients at the emergency department.

27. Myocardial infarct heterogeneity assessment by late gadolinium enhancement cardiovascular magnetic resonance imaging shows predictive value for ventricular arrhythmia development after acute myocardial infarction

29. Abstracts

30. Abstracts

33. Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention

34. Metabolic Syndrome and Risk of Restenosis in Patients Undergoing Percutaneous Coronary Intervention

36. Relationship between epicardial adipose tissue and subclinical coronary artery disease in patients with extra-cardiac arterial disease.

39. Autonomic dysfunction in patients with mild heart failure and coronary artery disease and the effects of add-on beta-blockade.

41. Negative inotropic effects of recombinant interleukin 2 in patients without left ventricular dysfunction.

42. Cardiac overexpression of human VEGF165 by recombinant Semliki Forest virus leads to adverse effects in pressure-induced heart failure

44. Carvedilol increases plasma vascular endothelial growth factor (VEGF) in patients with chronic heart failure.

45. Relationship between epicardial adipose tissue and subclinical coronary artery disease in patients with extra-cardiac arterial disease.

46. Prevalence of severe subclinical coronary artery disease on cardiac CT and MRI in patients with extra-cardiac arterial disease.

47. Calcification as a risk factor for rupture of abdominal aortic aneurysm.

48. Matrix metalloproteinases 2 and 3 gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention: Is there still room for determining genetic variation of MMPs for assessment of an increased risk of restenosis?

49. Clinical relevance of advanced glycation endproducts for vascular surgery.

50. Application of PET/SPECT imaging in vascular disease.

Catalog

Books, media, physical & digital resources